Hasta la próxima

Auto reproducción

Dr. Brentjens on CD19-Targeted T Cells in CLL and ALL

2 vistas • 07/14/23
Compartir
Empotrar
administrator
administrator
Suscriptores
0

Renier J. Brentjens, MD, PhD, associate professor, chief, Cellular Therapeutics Center, Memorial Sloan-Kettering Cancer Center, discusses clinical responses in patients with chronic lymphoblastic leukemia (CLL) or acute lymphoblastic leukemia (ALL) following infusion with CD19-Targeted T Cells.

Mostrar más
0 Comentarios sort Ordenar por
Comentarios de Facebook

Hasta la próxima

Auto reproducción